Overview Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient Status: No longer available Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient Details Lead Sponsor: AVEO Pharmaceuticals, Inc.